Pioneer Pharma on the road for $215m Hong Kong listing
Shanghai-based China Pioneer Pharma Holdings started gathering orders for its HK$1.67bn ($215m) Hong Kong IPO on October 22 as it looks to list by early November.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts